Cargando…
Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia
Background: Nutraceutical combinations (NCs) against hypercholesterolemia are increasing in the marketplace. However, the availability of NCs without monacolin K is scarce even though the statin-intolerant population needs it. Methods: This study is a parallel-group, randomized, placebo-controlled,...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324786/ https://www.ncbi.nlm.nih.gov/pubmed/35889769 http://dx.doi.org/10.3390/nu14142812 |
_version_ | 1784756884689911808 |
---|---|
author | Protic, Olga Di Pillo, Raffaele Montesanto, Alberto Galeazzi, Roberta Matacchione, Giulia Giuliani, Angelica Sabbatinelli, Jacopo Gurău, Felicia Silvestrini, Andrea Olivieri, Fabiola Antonicelli, Roberto Bonfigli, Anna Rita |
author_facet | Protic, Olga Di Pillo, Raffaele Montesanto, Alberto Galeazzi, Roberta Matacchione, Giulia Giuliani, Angelica Sabbatinelli, Jacopo Gurău, Felicia Silvestrini, Andrea Olivieri, Fabiola Antonicelli, Roberto Bonfigli, Anna Rita |
author_sort | Protic, Olga |
collection | PubMed |
description | Background: Nutraceutical combinations (NCs) against hypercholesterolemia are increasing in the marketplace. However, the availability of NCs without monacolin K is scarce even though the statin-intolerant population needs it. Methods: This study is a parallel-group, randomized, placebo-controlled, double-blind trial. We evaluated the effects of the NC containing phytosterols, bergamot, olive fruits, and vitamin K(2) on lipid profile and inflammatory biomarkers in 118 subjects (mean age ± SD, 57.9 ± 8.8 years; 49 men and 69 women) with hypercholesterolemia (mean total cholesterol ± SD, 227.4 ± 20.8 mg/dL) without clinical history of cardiovascular diseases. At baseline and 6 and 12 weeks of treatment, we evaluated lipid profile (total, LDL and HDL cholesterol, and triglycerides), safety (liver, kidney, and muscle parameters), and inflammatory biomarkers such as hs-CRP, leukocytes, interleukin-32, and interleukin-38 and inflammatory-microRNAs (miRs) miR-21, miR-126, and miR-146a. Results: Compared to the placebo, at 6 and 12 weeks, NC did not significantly reduce total cholesterol (p = 0.083), LDL cholesterol (p = 0.150), and triglycerides (p = 0.822). No changes were found in hs-CRP (p = 0.179), interleukin-32 (p = 0.587), interleukin-38 (p = 0.930), miR-21 (p = 0.275), miR-126 (p = 0.718), miR-146a (p = 0.206), myoglobin (p = 0.164), and creatine kinase (p = 0.376). Among the two reported, only one adverse event was probably related to the nutraceutical treatment. Conclusions: The evaluated nutraceutical combination did not change serum lipid profile and inflammatory parameters, at least not with the daily dose applied in the present study. |
format | Online Article Text |
id | pubmed-9324786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93247862022-07-27 Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia Protic, Olga Di Pillo, Raffaele Montesanto, Alberto Galeazzi, Roberta Matacchione, Giulia Giuliani, Angelica Sabbatinelli, Jacopo Gurău, Felicia Silvestrini, Andrea Olivieri, Fabiola Antonicelli, Roberto Bonfigli, Anna Rita Nutrients Article Background: Nutraceutical combinations (NCs) against hypercholesterolemia are increasing in the marketplace. However, the availability of NCs without monacolin K is scarce even though the statin-intolerant population needs it. Methods: This study is a parallel-group, randomized, placebo-controlled, double-blind trial. We evaluated the effects of the NC containing phytosterols, bergamot, olive fruits, and vitamin K(2) on lipid profile and inflammatory biomarkers in 118 subjects (mean age ± SD, 57.9 ± 8.8 years; 49 men and 69 women) with hypercholesterolemia (mean total cholesterol ± SD, 227.4 ± 20.8 mg/dL) without clinical history of cardiovascular diseases. At baseline and 6 and 12 weeks of treatment, we evaluated lipid profile (total, LDL and HDL cholesterol, and triglycerides), safety (liver, kidney, and muscle parameters), and inflammatory biomarkers such as hs-CRP, leukocytes, interleukin-32, and interleukin-38 and inflammatory-microRNAs (miRs) miR-21, miR-126, and miR-146a. Results: Compared to the placebo, at 6 and 12 weeks, NC did not significantly reduce total cholesterol (p = 0.083), LDL cholesterol (p = 0.150), and triglycerides (p = 0.822). No changes were found in hs-CRP (p = 0.179), interleukin-32 (p = 0.587), interleukin-38 (p = 0.930), miR-21 (p = 0.275), miR-126 (p = 0.718), miR-146a (p = 0.206), myoglobin (p = 0.164), and creatine kinase (p = 0.376). Among the two reported, only one adverse event was probably related to the nutraceutical treatment. Conclusions: The evaluated nutraceutical combination did not change serum lipid profile and inflammatory parameters, at least not with the daily dose applied in the present study. MDPI 2022-07-08 /pmc/articles/PMC9324786/ /pubmed/35889769 http://dx.doi.org/10.3390/nu14142812 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Protic, Olga Di Pillo, Raffaele Montesanto, Alberto Galeazzi, Roberta Matacchione, Giulia Giuliani, Angelica Sabbatinelli, Jacopo Gurău, Felicia Silvestrini, Andrea Olivieri, Fabiola Antonicelli, Roberto Bonfigli, Anna Rita Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia |
title | Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia |
title_full | Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia |
title_fullStr | Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia |
title_full_unstemmed | Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia |
title_short | Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia |
title_sort | randomized, double-blind, placebo-controlled trial to test the effects of a nutraceutical combination monacolin k-free on the lipid and inflammatory profile of subjects with hypercholesterolemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324786/ https://www.ncbi.nlm.nih.gov/pubmed/35889769 http://dx.doi.org/10.3390/nu14142812 |
work_keys_str_mv | AT proticolga randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT dipilloraffaele randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT montesantoalberto randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT galeazziroberta randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT matacchionegiulia randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT giulianiangelica randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT sabbatinellijacopo randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT guraufelicia randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT silvestriniandrea randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT olivierifabiola randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT antonicelliroberto randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia AT bonfigliannarita randomizeddoubleblindplacebocontrolledtrialtotesttheeffectsofanutraceuticalcombinationmonacolinkfreeonthelipidandinflammatoryprofileofsubjectswithhypercholesterolemia |